{
  "name" : "dacemirror.sci-hub.se_journal-article_bfa534288d34d77a65889e5e41ae09f6_xing2019.pdf",
  "metadata" : {
    "source" : "CRF",
    "title" : "Self-Assembling Endogenous Biliverdin as a Versatile Near-Infrared Photothermal Nanoagent for Cancer Theranostics",
    "authors" : [ "Ruirui Xing", "Qianli Zou", "Chengqian Yuan", "Luyang Zhao", "Rui Chang", "Xuehai Yan" ],
    "emails" : [ "yanxh@ipe.ac.cn" ],
    "sections" : [ {
      "heading" : null,
      "text" : "CommuniCation\n1900822 (1 of 8) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nwww.advmat.de"
    }, {
      "heading" : "Self-Assembling Endogenous Biliverdin as a Versatile",
      "text" : ""
    }, {
      "heading" : "Near-Infrared Photothermal Nanoagent for Cancer",
      "text" : ""
    }, {
      "heading" : "Theranostics",
      "text" : "Ruirui Xing, Qianli Zou, Chengqian Yuan, Luyang Zhao, Rui Chang, and Xuehai Yan*\nDr. R. R. Xing, Dr. Q. L. Zou, Dr. C. Q. Yuan, Dr. L. Y. Zhao, Dr. R. Chang, Prof. X. H. Yan State Key Laboratory of Biochemical Engineering Institute of Process Engineering Chinese Academy of Sciences Beijing 100190, China E-mail: yanxh@ipe.ac.cn Dr. R. Chang, Prof. X. H. Yan School of Chemical Engineering University of Chinese Academy of Sciences Beijing 100049, China Prof. X. H. Yan Center for Mesoscience Institute of Process Engineering Chinese Academy of Sciences Beijing 100190, China\nThe ORCID identification number(s) for the author(s) of this article can be found under https://doi.org/10.1002/adma.201900822.\nDOI: 10.1002/adma.201900822\nof noninvasiveness, minimal toxicity, high spatiotemporal selectivity, and less initiation of resistance.[1–3] Furthermore, photothermal nanomaterials can serve as contrast agents in photoacoustic imaging (PAI) for the diagnosis of tumors with high spatial resolution and penetration depth.[4] Supported by real-time diagnostic PAI, the tumor accumulation of photothermal nanomaterials as well as the therapeutic response can be accurately monitored, enabling the administration of medicine with enhanced efficacy and minimized side effects.[5] Therefore, considerable efforts have been dedicated to the development of efficient photothermal nanomaterials with the aim of promoting tumor diagnosis and therapy. Numerous photothermal nanomaterials, including inorganic nanomaterials, lightabsorbing polymers, porphyrins, and chlorins, have been investigated, but each has disadvantages that hamper the potential for clinical translation.[6–9] For instance, light-absorbing inorganic and polymeric nanomaterials usually suffer from slow metabolism, while porphyrins and chlorins lack inherent near-infrared (NIR)\nabsorption. Hence, new photothermal nanomaterials with improved metabolic and optical properties are in high demand to explore the potential of photothermal precision medicine.\nAmong multiple biological pigments, linear tetrapyrrolic pigments are characterized by high flexibility, intense NIR absorption, and superior biocompatibility, which are highly desirable properties for photothermal nanomaterials.[10] Importantly, these pigments have clear metabolic pathways since they are endogenic molecules in organisms. For example, bile pigments are metabolic products of certain porphyrins and formed in many organisms. Degradation of heme from red cells, myoglobin, or enzymes leads to production of bilirubin (BR). Biliverdin (BV) is formed as an intermediate step and can be reduced and excreted in bile (Figure 1a). Other bile pigments are also found in certain animals (e.g., aplysioviolin) or plants (e.g., phycobilins or phytochrome chromophore), and BV is the most widespread in nature.[11] In addition, BV exhibits multiple beneficial biological activities in humans, such as antioxidation, antimutagenicity, the prevention of vascular stenosis, and the suppression of alloimmune responses.[12] Using BV as an example, we demonstrate herein that the self-assembly\nPhotothermal nanomaterials that integrate multimodal imaging and therapeutic functions provide promising opportunities for noninvasive and targeted diagnosis and treatment in precision medicine. However, the clinical translation of existing photothermal nanoagents is severely hindered by their unclear physiological metabolism, which makes them a strong concern for biosafety. Here, the utilization of biliverdin (BV), an endogenic near-infrared (NIR)-absorbing pigment with well-studied metabolic pathways, to develop photothermal nanoagents with the aim of providing efficient and metabolizable candidates for tumor diagnosis and therapy, is demonstrated. It is shown that BV nanoagents with intense NIR absorption, long-term photostability and colloidal stability, and high photothermal conversion efficiency can be readily constructed by the supramolecular multicomponent self-assembly of BV, metal-binding short peptides, and metal ions through the reciprocity and synergy of coordination and multiple noncovalent interactions. In vivo data reveal that the BV nanoagents selectively accumulate in tumors, locally elevate tumor temperature under mild NIR irradiation, and consequently induce efficient photothermal tumor ablation with promising biocompatibility. Furthermore, the BV nanoagents can serve as a multimodal contrast for tumor visualization through both photoacoustic and magnetic resonance imaging. BV has no biosafety concerns, and thereby offers a great potential in precision medicine by integrating multiple theranostic functions."
    }, {
      "heading" : "Cancer Theranostics",
      "text" : "Photothermal therapy (PTT) by combining photothermal nanomaterials and light irradiation is a clinically promising therapeutic modality in tumor treatments. It has the advantages\nAdv. Mater. 2019, 1900822\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1900822 (2 of 8)\nof endogenic NIR-absorbing pigments is a robust and versatile strategy to fabricate highly efficient and metabolizable photothermal nanomaterials (Figure 1a,c). We show that well-defined BV nanoagents with long-term colloidal stability are readily constructed by the supramolecular self-assembly of BV and metal-binding short peptides. Compared to BV monomers, the BV nanoagents possess broader NIR absorption, highly improved photostability, and higher photothermal conversion efficiency, making it an excellent candidate for use in PTT and PAI. Significantly, metal ions such as Mn2+ can be integrated into the BV nanoagents to further enhance the photostability of the nanoagents and to endow the nanoagents with magnetic resonance.[13] In addition, BV nanoagents exhibit prolonged blood circulation and improved tumor accumulation. Taken\nAdv. Mater. 2019, 1900822\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1900822 (3 of 8)\ntogether, these properties of BV nanoagents indicate highly efficient in vivo multimodal tumor bioimaging and NIR photothermal tumor ablation with promising biocompatibility and biosafety (Figure 1e). To the best of our knowledge, this work represents the first paradigm of photothermal nanomaterials using endogenic NIR-absorbing pigments and thus provides a kind of easy-available and promising theranostic nanoagents toward tumor precision diagnosis and treatment.\nDue to their limited aqueous solubility, linear tetrapyrrolic pigments mostly exist bound to proteins in vivo while retaining strong coordination with metal ions.[14] Inspired by these interactions of linear tetrapyrrolic pigments with proteins and metal ions, BV nanoparticles were self-assembled using BV, Z-Histidine-Obzl (ZHO), and Mn2+ as the building blocks. ZHO was chosen as a self-assembling short peptide model that can coordinate with metal ions through the imidazole side chain and tune BV self-assembly process through the aromatic groups. Short peptides are of particular interest as building blocks for constructing functional materials due to their resemblance to proteins, structural diversity, versatile functionality, and excellent biocompatibility.[15] Mn2+ was selected for inducing coordination and as a contrast for magnetic resonance imaging (MRI) with good biocompatibility. The self-assembly of BV and ZHO in water through noncovalent interactions generates well-dispersed ZHO/BV nanoparticles (ZB NPs). Consequently, ZHO/BV/Mn2+ nanoparticles (ZBMn NPs) were facilely prepared by inserting Mn2+ into freshly prepared ZB NPs. Dynamic light scattering (DLS) profiles show that the ZB NPs and ZBMn NPs have similar average diameters of 120 ± 20 nm (Figure 1d), suggesting that the Mn2+ has a negligible impact on the morphology of the self-assembled ZB NPs. Scanning electron microscopy (SEM) and transmission electron microscopy (TEM) images confirm that both the ZB NPs and ZBMn NPs are spherical, solid nanoparticles with similar morphology (Figure 1f–i). The inclusion of Mn2+ in the ZBMn NPs was evidenced by energy-dispersive spectroscopy (EDS) mapping (Figure S1, Supporting Information) and UV–vis absorption spectra (Figure 1b). Compared to the spectrum of ZB NPs, that of ZBMn NPs under the same pH showed a slightly blueshifted absorption band at ≈700 and ≈400 nm, likely due to the transformation of BV into a porphyrin-like coordination compound upon coordination with Mn2+. In addition, compared to the spectrum of monomeric BV in 0.1 m NaOH (pH = 13.16) or in H2O after predissolved in 2% DMSO with a pH of 6.97, the NIR absorption of the ZB NPs (pH = 6.82) and ZBMn NPs (pH = 7.04) showed broaden bands. This will be favorable for biological applications because it shifts the absorption spectrum edge to the longer NIR region. The light energy absorbed by photothermal materials usually has three main relaxation pathways: the generation of fluorescence, heat, and photochemical reactions. For the purpose of enhancing photothermal conversion, photothermal materials that exhibit photochemical reaction and low fluorescence quantum yield are preferred.[2] Intrinsically, monomeric BV exhibits poor fluorescence at room temperature because monomeric BV has flexible molecular conformation and the fluorescence can easily be quenched by intramolecular vibrations.[16] However, monomeric BV almost loses its NIR absorption due to photooxidation upon laser irradiation (730 nm, 0.3 W cm−2) for 10 min (Figure S2a,\nSupporting Information). This photodegradation limits the direct application of BV as a photothermal agent. Under the same irradiation, the absorption bands of the ZB NPs decreased only slightly, while the absorption spectrum of the ZBMn NPs showed no discernible change (Figure S2b, Supporting Information), indicating that self-assembled BV nanoparticles can greatly inhibit the photodegradation process and that BV in the ZBMn NPs could be highly resistant to photodegradation. Based on the broadened NIR band and improved photostability, the ZB NPs and ZBMn NPs are expected to be promising nanoagents for photothermal applications.\nFor biomedical applications, the stability of nanoparticles in biological media is a key factor that impacts the size-dependent properties.[17] Hence, we evaluated the colloidal stability of the ZBNPs and ZBMn NPs under various conditions. Notably, BV is soluble in 0.1 m NaOH but precipitates quickly when the pH of the solution is changed to neutral conditions (Figure S3, Supporting Information). Similarly, the coordinated peptide, ZHO/Mn2+, and coordinated BV, BV/Mn2+, also precipitate within a short time period, suggesting that these metal complexes have poor colloidal stability. In contrast, both the ZB NPs and ZBMn NPs size distributions were not altered during one month of aging (Figure S2c, Supporting Information), indicating a great stability. Importantly, the NIR absorption bands of the ZB NPs and ZBMn NPs remained nearly unchanged during aging (Figure S2d, Supporting Information). When ZBMn NPs were incubated in physiological culture medium (Dulbecco’s modified Eagle (DMEM) medium containing 10% fetal bovine serum (FBS) and 1% penicillin– streptomycin) at 37 °C for 48 h or one week, their UV–vis spectra change barely, excepting a minor attenuation rooting from particle sedimentation (Figure 2a). No obvious change in their DLS profile was observed at 48 h. Minor increase in their DLS profile was observed at the 7th day, mainly because of the protein adsorption (Figure 2b). The DLS measurements of the diluted ZBMn NP samples showed no significant change, indicating that the coordination and noncovalent interactions that characterize ZBMn NPs exhibit good resistance to dilution (Figure 2c). Subsequently, we evaluated the cell viability and PTT efficacy of the ZB NPs and ZBMn NPs in vitro (Figure 2d). Without irradiation, no significant change in viability was found for the cells incubated with the ZB NPs or ZBMn NPs, even at a high concentration of 5 mg mL−1, indicating that these nanoagents are highly biocompatible. The evaluation performed on MCF-7 cells showed that the cell viability was inhibited by the combination of the BV nanoagents and mild irradiation (730 nm, 0.3 W cm−2, 1 min). The IC50 values for the PTT based on the ZB NPs and ZBMn NPs are ≈8 and ≈8.5 µg mL−1, respectively. The enhanced colloidal stability of the ZB NPs and ZBMn NPs under various conditions indicates that these nanomaterials are promising candidates for in vivo applications.\nTo gain insight into the self-assembly mechanism, the ZB NPs and ZBMn NPs were analyzed by Fourier transform infrared (FTIR) spectroscopy in comparison with pure ZHO and BV. The CO stretching vibration bands of pure BV and ZHO were located at 1706 and 1695 cm−1, respectively. In contrast, the corresponding CO stretching vibration band of the ZB NPs broadened and shifted to 1719 cm−1 (Figure S4a, Supporting Information). This shift confirms that noncovalent\nAdv. Mater. 2019, 1900822\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1900822 (4 of 8)\ninteractions between peptide and BV molecules are involved in the formation of the ZB NPs. After the addition of Mn2+, the CO stretching vibration bands of the ZB NPs were almost unaltered, suggesting that the CO groups are not involved in the coordination. Significant differences between the spectra of the ZB NPs and ZBMn NPs are observed in their stretching vibration bands of the NH and COO groups. The ZB NPs and ZBMn NPs showed N–H stretching vibration bands at 3313 and 3392 cm−1, respectively, along with COO stretching vibration bands at 1454 and 1420 cm−1, respectively (Figure S4b, Supporting Information). The differences clearly demonstrated that the NH and COO groups of the ZBMn NPs participated in coordination with Mn2+. Quantitative analysis of the components of the ZBMn NPs revealed that the molar ratio of ZHO:BV:Mn2+ in the NPs was approximately 6:2:5. Based on the quantitative analysis results, the formation processes of the ZB NPs were simulated by an allatom molecular dynamics (MD) method. The results showed that all the solute molecules assembled into a particle-similar after 150 ns of dynamic simulation (Figure S4c–e, Supporting Information). In the resulting particle, BV molecules were distributed both on the surface and within the interior of the particle. The energy analysis results showed that the self-assembly of BV and ZHO is driven by multiple noncovalent interactions, including hydrophobic effects, π–π interactions, and hydrogen bonding with water. The interaction energy between BV and ZHO is 64.4 kcal mol−1 per BV molecule, while the energy of the BV–BV interaction is as strong as 92.4 kcal mol−1 per BV molecule, indicating strong intermolecular hydrophobic and π–π interactions. In contrast, hydrogen bonds with water are found to have an average energy of ≈6.1–9.8 kcal mol−1, which greatly contributes to stability of the colloidal (Figures S4c and S5a, Supporting Information). To clarify the coordination interactions, the molecular spatial coordination conformations of BV and ZHO with Mn2+ were simulated by a density functional theory (DFT) method. The results showed that Mn2+ not only interacts with the pyrrole groups of BV and forms a porphyrin-like coordination compound, but also combines with the carboxylic groups of BV molecules (Figures S4d and S5b, Supporting Information). In addition, the Mn2+ in the center of the porphyrin-like coordination compound can further coordinate with the imidazole group of ZHO (Figures S4e and S5c, Supporting Information), proving an additional interaction to bind BV and ZHO molecules. The attractive interactions (such as π-stacking and hydrophobic effect) between BV and peptide drive the building blocks for self-assembly, while the carboxyl groups of the BV can be deprotonated and maintain the colloidal stability through the electrostatic repulsion (zeta potential of ZBNPs and ZBMn NPs is −29.4 and −23.3 mV, respectively). The balance and compromise between the attractive interaction\nAdv. Mater. 2019, 1900822\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1900822 (5 of 8)\ncontaining π-stacking and hydrophobic effect and the repulsive interaction of electrostatic force lead to the formation of welldefined nanoparticles.[7,18]\nVarious metal ions can be used to construct BV nanoparticles. For example, the self-assembly of BV and ZHO in the presence of Cu2+- or Zn2+-generated ZHO/BV/Cu2+ nanoparticles (ZBCu NPs) or ZHO/BV/Zn2+ nanoparticles (ZBZn NPs), respectively. The DLS measurement showed that the average sizes of the ZBCu NPs and ZBZn NPs are 105 ± 15 and 110 ± 10 nm, respectively (Figure S6a,b, Supporting Information). SEM images revealed that the ZBCu NPs and ZBZn NPs are well-defined nanoparticles with uniform sizes (Figure S6c,d, Supporting Information). Similar to the ZBMn NPs, the ZBCu NPs and ZBZn NPs also possess broadened NIR absorption bands (Figure S7, Supporting Information) and enhanced photostability (Figure S8a,b, Supporting Information). Not surprisingly, changing ZHO to other metal-binding short peptides, such as H-His-Phe-βNA (HHP), without compromising the interactions that drive the multicomponent coordination selfassembly is also feasible. The DLS profiles demonstrated that the self-assembly of BV and HHP in the presence of various metal ions (Mn2+, Cu2+, and Zn2+) forms BV nanoparticles with a narrow size distribution (Figure S9, Supporting Information). These results indicate that BV photothermal nanoagents can be facilely constructed through a self-assembly procedure.\nWhen an aqueous solution of ZB NPs or ZBMn NPs (0.2 mg mL−1 BV) was exposed to mild laser irradiation (0.3 W cm−1, 730 nm), the temperature of the solution increased by ≈25 °C in 10 min, indicating efficient photothermal conversion. In the absence of the nanoagents, the temperature of BV in the molecular state (dissolve in 0.1 m NaOH) increased by about 6 °C due to photooxidation upon laser irradiation (730 nm, 0.3 W cm−2) (Figure S10, Supporting Information). The temperature of pure water increased by less than 3 °C under the same laser conditions (Figure 3a), confirming that the photothermal conversion is due to the photothermal effect of the ZB NPs and ZBMn NPs. Intriguingly, the temperature increase can be manipulated by changing the concentration of the nanoagents and the laser power. For a BV concentration of 1.0 mg mL−1 and a laser power of 0.3 W cm−1, the temperature of the solutions reached nearly 50 °C (Figure 3b). For a BV concentration of 0.2 mg mL−1 and a laser power of 1.0 W cm−1, the ZBMn NPs effectively increased the temperature to 60 °C (Figure 3c). In contrast, the temperature reached by irradiating ZB NPs at a laser power of 1.0 W cm−1 was lower than at the laser power of 0.25 and 0.5 W cm−1. Continuous irradiation-cooling measurements were carried out to further investigate the photothermal stability of the ZB NPs and ZBMn NPs. The samples were laser irradiated (0.5 W cm−1, 730 nm) for 10 min and then cooled to room temperature, and the irradiationcooling cycle was repeated three times. Significantly, the ZBMn NPs showed a high photothermal effect during all three cycles of irradiation, while the ZB NPs tolerated only one cycle of laser irradiation (Figure 3d,e). The decreased photothermal effect of the ZB NPs in comparison to the ZBMn NPs is due to the fact that the large agglomerate appeared after one cycle of laser irradiation. This may attribute to the decreased hydrogen bonding interactions between building blocks inside the ZB NPs, leading to the exposure of the hydrophobic domains. By contrast, the\nAdv. Mater. 2019, 1900822\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1900822 (6 of 8)\nintroduction of strong coordination interaction in the case of the ZBMn NPs enables the condense stacking of BV and peptide building blocks and thus weakens the interaction between building blocks and water molecules. Based on the heating and cooling curve, the photothermal efficiency of the ZBMn NPs was calculated following a reported formula (Figure 3f). The result showed that the ZBMn NPs have a high photothermal conversion efficiency (η value) of 34.3%, which is comparable to the reported values of representative inorganic (10–20%) and organic photothermal nanomaterials (under 40%).[19]\nTo validate the colloidal stability, the blood circulation and biodistribution of the ZB NPs and ZBMn NPs were studied in vivo. Since endogenic BV mainly exists in the bile and urine, it did not interfere with the quantitative analysis of the ZB NPs and ZBMn NPs in vivo. The blood circulation data showed that the pharmacokinetics of both the ZB NPs and the ZBMn NPs follow a two-compartment decrease model (Figure 4a; Figures S11 and S12, Supporting Information). The half-lives of the ZB NPs are 0.71 and 22 h, respectively, while the half-lives of the ZBMn NPs are 1.4 and 22 h, respectively. These data indicates that both the ZB NPs and ZBMn NPs have prolonged blood circulation time and that the ZBMn NPs have a better performance in the initial decay process. To analyze the in vivo distribution of the NPs, tumor-bearing mice were intravenously injected with ZB NPs or ZBMn NPs (4 mg kg−1 BV), and the BV concentration in the tissues (including heart, spleen, kidney, liver, and lung) and tumors were analyzed at various time points after the injection. The data showed that the ZB NPs and ZBMn NPs are mainly taken up by the liver, likely through the mononuclear phagocyte system (Figure 4b,c). Significantly, the maximum accumulation of both ZB NPs and ZBMn NPs in tumors occurred 6 h after the injection, reaching 4.83% and 9.22% ID g−1, respectively. The better tumor accumulation of the ZBMn NPs is consistent with their better performance in the blood circulation. As expected, the nanoagents were almost completely cleared at 72 h after the injection.\nThe potential of the ZB NPs and ZBMn NPs as contrast agents for tumor imaging was evaluated in an MCF-7 xenograft tumor model. Since the ZB NPs and ZBMn NPs can convert light to heat, we first investigated their applications for PAI. Mice bearing MCF-7 tumors were injected with ZB NPs or ZBMn NPs (4 mg kg−1 BV) through the tail vein and then imaged by a whole-body PAI system. The results showed that both the ZB NPs and ZBMn NPs accumulated near the tumors in a time-dependent manner, and the tumors were distinguishable from other parts of the body at 4 or 6 h postinjection (Figure 4d). Intensity analysis revealed that the accumulation of the ZB NPs and ZBMn NPs in tumors both reached a maximum at 6 h postinjection (Figure 4f). The signal maximum of the ZBMn NPs is higher than that of the ZB NPs, likely due to the integration of coordination interactions, which endues ZBMn NPs with better stability in blood circulation in vivo. As a clinical tumor imaging modality, MRI provides superior spatial resolution, high contrast, and deep penetration depth.[20] Hence, we investigated the application of the ZBMn NPs for MRI. T1-weighted images acquired before the intravenous tail injection of the ZBMn NPs and at various time points afterward showed a detectible enhancement of T1-weighted contrast around the tumor region after the injection (Figure 4e).\nQuantitative analysis showed that the MRI signal in the tumor region reached a maximum at 6 h postinjection (Figure 4g). In contrast, no detectible contrast enhancement was observed when the ZB NPs were monitored by MRI, confirming that the MRI signal is due to the presence of Mn2+. The PAI and MRI results suggest that ZBMn NPs are powerful candidates for multimodal tumor imaging. In vivo PTT was evaluated in MCF-7 tumor-bearing mice. After the intravenous tail injection of the 5% glucose aqueous solution (blank group), ZB NPs (4 mg kg−1 BV, ZB NPs group) or ZBMn NPs (4 mg kg−1 BV, ZBMn NPs group) for 6 h, the mouse tumors were irradiated by a 730 nm laser (0.3 W cm−2) for 10 min. During the irradiation, the surface temperature of the tumor was monitored (Figure 4h; Figure S13, Supporting Information). The mean tumor temperature in the ZB NPs group and the ZBMn NPs group gradually increased, reaching 58.2 and 58.7 °C, respectively, at the end of the irradiation. In contrast, the mean tumor temperature of the mice injected with 5% glucose increased only to 42.9 °C under identical irradiation. These data suggests that the ZB NPs and ZBMn NPs are effective for in vivo PTT since a temperature of 50 °C is sufficient to cause irreversible damage to cancer cells.[2] After the treatment, the tumors were monitored. In the mice in the ZB NPs group and the ZBMn NPs group, photothermal lesions emerged from the interior of the tumors and induced redness, swelling, and scarring in the tumors. The scabs gradually vanished, and the skin recovered almost to normal on the 24th day after the treatment. Tumor volume profiles showed that the tumors in both the ZB NPs group and in the ZBMn NPs group were ablated with no recurrence during the observation period, while the tumors in the blank group exhibited rapid growth (Figure 4i,j). Importantly, the body weight of the mice monitored over the entire period suggests that PTT based on these ZB NPs and ZBMn NPs is biocompatible (Figure S14, Supporting Information). Good biocompatibility was also clearly confirmed by the major organs (heart, liver, spleen, lung, and kidneys) harvested at the end of the observation period, which maintained their typical structural phenotypes and did not exhibit appreciable lesions (Figure S15, Supporting Information). Importantly, no skin photo - sensitization was found when the mice were housed in a specific pathogen-free environment with a regular 12 light/12 dark cycle. The absence of skin photosensitization is consistent with the fact that BV is inherently not a photosensitizer, a property that provides BV nanoagents with a distinct advantage over porphyrins and chlorins, which usually result in prolonged skin photosensitization. These data indicate that the BV nanoagents are efficient and biocompatible photothermal agents for PTT.\nIn conclusion, we have for the first time developed an endogenic NIR-absorbing photothermal nanoagent based on the cooperative self-assembly among the naturally-occurring BV, short peptides and metal ions. The BV nanoagents have well-defined nanostructures, excellent photostability and colloidal stability, high photothermal conversion efficiency, as well as prolonged blood circulation. Importantly, MRI sensitivity is readily imparted by incorporating Mn2+ into the BV nanoagents. These properties made it possible for in vivo application of BV nanoagents for MRI, PAI, and PTT. Since many biological pigments have similar structures and properties to those of BV, the design concept we proposed for BV can be explored for other biological pigments to manipulate the\nAdv. Mater. 2019, 1900822\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1900822 (7 of 8)\nphotothermal properties of the resulting nanomaterials, with the goal to enhance the NIR absorption and improve the photothermal conversion efficiency. As demonstrated, the concept is versatile for many metal-binding short peptides and metal ions. Targeting peptides such as Arg-Gly-Asp (RGD), transferrin (Tf), lactoferrin (Lf), whose receptors are preferentially expressed in tumors, can be integrated into His-containing peptides for optimizing the tumor targeting delivery apart from passive enhanced permeability and retention (EPR) effect.[21] The MRI sensitivity of the nanomaterials can also be optimized, and more imaging functions such as positron emission tomography can be introduced using other metal ions (such as Gd3+ and 64Cu2+) as contrast\nAdv. Mater. 2019, 1900822\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1900822 (8 of 8)\nagents.[22] Because endogenic pigments, such as BV, are biodegradable through well-studied metabolic pathways, and short peptides are also composed of endogenic amino acids, photothermal nanomaterials using endogenic pigments and peptides are highly biocompatible with superior biosafety. Therefore, the multifunctional biomolecular photothermal nanomaterials and relevant fabrication techniques developed in this work may pave the way for the new generation of photothermal agents and promote the clinical translation of PTT modality.\nSupporting Information Supporting Information is available from the Wiley Online Library or from the author."
    }, {
      "heading" : "Acknowledgements",
      "text" : "All animal experiments were performed in compliance with the Guide for the Care and Use of Laboratory Animals and were approved by the Experimental Animal Ethics Committee in Beijing. The authors acknowledge financial support from the National Natural Science Foundation of China (Project Nos. 21802144, 21522307, 21773248, and 21802143), the National Natural Science Fund BRICS STI Framework Programme (No. 51861145304), and Innovation Research Community Science Fund (No. 21821005) as well as the Key Research Program of Frontier Sciences of the Chinese Academy of Sciences (CAS, Grant No. QYZDB-SSW-JSC034). The authors also appreciate Prof. Mingjun Zhang (The Ohio State University) for his critical reading of this manuscript."
    }, {
      "heading" : "Conflict of Interest",
      "text" : "The authors declare no conflict of interest."
    }, {
      "heading" : "Keywords",
      "text" : "biliverdin, biosafety, endogenic pigment, photothermal therapy, self-assembly\nReceived: February 1, 2019 Revised: February 13, 2019\nPublished online:\n[1] a) E. K. Chow, D. Ho, Sci. Transl. Med. 2013, 5, 216rv4; b) H. S. Jung, P. Verwilst, A. Sharma, J. Shin, J. L. Sessler, J. S. Kim, Chem. Soc. Rev. 2018, 47, 2280; c) K. K. Ng, G. Zheng, Chem. Rev. 2015, 115, 11012; d) X. Li, H. Bai, Y. Yang, J. Yoon, S. Wang, X. Zhang, Adv. Mater. 2019, 31, 1805092; e) L. Zhao, Y. Liu, R. Chang, R. Xing, X. H. Yan, Adv. Funct. Mater. 2019, 29, 1806877. [2] a) X. Li, S. Lee, J. Yoon, Chem. Soc. Rev. 2018, 47, 1174; b) D. Jaque, L. M. Maestro, B. del Rosal, P. Haro-Gonzalez, A. Benayas, J. L. Plaza, E. M. Rodriguez, J. G. Sole, Nanoscale 2014, 6, 9494. [3] a) P. Zhang, Y. Cui, C. F. Anderson, C. Zhang, Y. Li, R. Wang, H. Cui, Chem. Soc. Rev. 2018, 47, 3490; b) X. Li, C. Y. Kim, S. Lee, D. Lee, H. M. Chung, G. Kim, S. H. Heo, C. Kim, K. S. Hong, J. Yoon, J. Am. Chem. Soc. 2017, 139, 10880. [4] L. H. V. Wang, S. Hu, Science 2012, 335, 1458. [5] a) J. Weber, P. C. Beard, S. E. Bohndiek, Nat. Methods 2016, 13,\n639; b) X. Zheng, L. Wang, S. Liu, W. Zhang, F. Liu, Z. Xie, Adv.\nFunct. Mater. 2018, 28, 1706507; c) S. Goel, C. A. Ferreira, F. Chen, P. A. Ellison, C. M. Siamof, T. E. Barnhart, W. Cai, Adv. Mater. 2018, 30, 1704367. [6] E. K. Lim, T. Kim, S. Paik, S. Haam, Y. M. Huh, K. Lee, Chem. Rev. 2015, 115, 327. [7] Q. L. Zou, M. Abbas, L. Y. Zhao, S. K. Li, G. Z. Shen, X. H. Yan, J. Am. Chem. Soc. 2017, 139, 1921. [8] a) R. R. Xing, K. Liu, T. F. Jiao, N. Zhang, K. Ma, R. Y. Zhang, Q. L. Zou, G. H. Ma, X. H. Yan, Adv. Mater. 2016, 28, 3669; b) H. F. Sun, S. K. Li, W. Qi, R. R. Xing, Q. L. Zou, X. H. Yan, Colloids Surf. A 2018, 538, 795. [9] a) M. Ferrari, Nat. Rev. Cancer 2005, 5, 161; b) Z. Liu, W. B. Cai, L. N. He, N. Nakayama, K. Chen, X. M. Sun, X. Y. Chen, H. J. Dai, Nat. Nanotechnol. 2007, 2, 47. [10] a) E. Talafant, Nature 1956, 178, 312; b) W. Rudiger, Angew. Chem., Int. Ed. 1970, 9, 473; c) S. H. Bhoo, S. J. Davis, J. Walker, B. Karniol, R. D. Vierstra, Nature 2001, 414, 776; d) G. S. Filonov, K. D. Piatkevich, L. M. Ting, J. H. Zhang, K. Kim, V. V. Verkhusha, Nat. Biotechnol. 2011, 29, 757; e) X. K. Shu, A. Royant, M. Z. Lin, T. A. Aguilera, V. Lev-Ram, P. A. Steinbach, R. Y. Tsien, Science 2009, 324, 804. [11] a) R. Lemberg, Lancet 1951, 257, 1018; b) K. Yamashita, J. McDaid, R. Ollinger, T. Y. Tsui, P. O. Berberat, A. Usheva, E. Csizmadia, R. N. Smith, M. P. Soares, F. H. Bach, FASEB J. 2004, 18, 765. [12] a) B. Wegiel, D. Gallo, E. Csizmadia, T. Roger, E. Kaczmarek, C. Harris, B. S. Zuckerbraun, L. E. Otterbein, Proc. Natl. Acad. Sci. USA 2011, 108, 18849; b) R. Ollinger, K. Yamashita, M. Bilban, A. Erat, P. Kogler, M. Thomas, E. Csizmadia, A. Usheva, R. Margreiter, F. H. Bach, Cell Cycle 2007, 6, 39; c) T. Jansen, A. Daiber, Front. Pharmacol. 2012, 3, 30. [13] a) H. M. Chen, W. Z. Zhang, G. Z. Zhu, J. Xie, X. Y. Chen, Nat. Rev. Mater. 2017, 2, 17024; b) S. Wang, J. Lin, Z. Wang, Z. Zhou, N. Lu, Y. Liu, R. Bai, X. Fu, O. Jacobson, W. Fan, J. Qu, S. Chen, T. Wang, P. Huang, X. Chen, Adv. Mater. 2017, 29, 1701013; c) D. Yoo, J. H. Lee, T. H. Shin, J. Cheon, Acc. Chem. Res. 2011, 44, 863. [14] a) I. Sovago, B. Harman, I. Kolozsvari, F. Matyuska, Inorg. Chim. Acta 1985, 106, 181; b) R. A. Velapoldi, O. Menis, Clin. Chem. 1971, 17, 1165; c) J. Fog, B. Bugge-Asperheim, Nature 1964, 203, 756. [15] a) J. Wang, K. Liu, R. R. Xing, X. H. Yan, Chem. Soc. Rev. 2016, 45.5589; b) M. Abbas, Q. L. Zou, S. K. Li, X. H. Yan, Adv. Mater. 2017, 29, 1605021; c) L. Adler-Abramovich, E. Gazit, Chem. Soc. Rev. 2014, 43, 6881; d) K. Liu, R. Xing, Q. Zou, G. Ma, H. Möhwald, X. Yan, Angew. Chem., Int. Ed. 2016, 55, 3036. [16] a) E. A. Rodriguez, G. N. Tran, L. A. Gross, J. L. Crisp, X. Shu, J. Y. Lin, Y. T. Roger, Nat. Methods 2016, 13, 763; b) P. S. Song, Q. Chae, D. A. Lightner, W. R. Briggs, D. Hopkins, J. Am. Chem. Soc. 1973, 95, 7892. [17] L. B. Wu, J. Zhang, W. Watanabe, Adv. Drug Delivery Rev. 2011, 63, 456. [18] a) S. K. Li, Q. L. Zou, Y. X. Li, C. Q. Yuan, R. R. Xing, X. H. Yan, J. Am. Chem. Soc. 2018, 140, 10794; b) Y. X. Li, Q. L. Zou, C. Q. Yuan, S. K. Li, R. R. Xing, X. H. Yan, Angew. Chem., Int. Ed. 2018, 57, 17084. [19] Z. B. Sun, H. H. Xie, S. Y. Tang, X. F. Yu, Z. N. Guo, J. D. Shao, H. Zhang, H. Hao, H. Y. Wang, P. Chu, Angew. Chem., Int. Ed. 2015, 54, 11526. [20] a) M. D. Fox, M. E. Raichle, Nat. Rev. Neurosci. 2007, 8, 700; b) E. Terreno, D. Delli Castelli, A. Viale, S. Aime, Chem. Rev. 2010, 110, 3019. [21] a) E. Jin, B. Zhang, X. Sun, Z. Zhou, M. Radosz, J. Am. Chem. Soc. 2013, 135, 933; b) E. Ruoslahti, Adv. Mater. 2012, 24, 3747. [22] a) C. Alric, J. Taleb, G. Le Duc, C. Mandon, C. Billotey, A. Le Meur-He rland, T. Brochard, F. Vocanson, M. Janier, P. Perriat, S. Roux, O. Tillement, J. Am. Chem. Soc. 2008, 130, 5908; b) V. J. Pansare, S. Hejazi, W. J. Faenza, R. K. Prud’homme, Chem. Mater. 2012, 24, 812.\nAdv. Mater. 2019, 1900822"
    } ],
    "references" : [ {
      "title" : "Chem",
      "author" : [ "Q.L. Zou", "M. Abbas", "L.Y. Zhao", "S.K. Li", "G.Z. Shen", "X.H. Yan", "J. Am" ],
      "venue" : "Soc. 2017, 139",
      "citeRegEx" : "7",
      "shortCiteRegEx" : null,
      "year" : 1921
    } ],
    "referenceMentions" : [ {
      "referenceID" : 0,
      "context" : "containing π-stacking and hydrophobic effect and the repulsive interaction of electrostatic force lead to the formation of welldefined nanoparticles.[7,18] Various metal ions can be used to construct BV nanoparticles.",
      "startOffset" : 149,
      "endOffset" : 155
    } ],
    "year" : 2019,
    "abstractText" : "Dr. R. R. Xing, Dr. Q. L. Zou, Dr. C. Q. Yuan, Dr. L. Y. Zhao, Dr. R. Chang, Prof. X. H. Yan State Key Laboratory of Biochemical Engineering Institute of Process Engineering Chinese Academy of Sciences Beijing 100190, China E-mail: yanxh@ipe.ac.cn Dr. R. Chang, Prof. X. H. Yan School of Chemical Engineering University of Chinese Academy of Sciences Beijing 100049, China Prof. X. H. Yan Center for Mesoscience Institute of Process Engineering Chinese Academy of Sciences Beijing 100190, China The ORCID identification number(s) for the author(s) of this article can be found under https://doi.org/10.1002/adma.201900822.",
    "creator" : "Adobe InDesign CS6 (Macintosh)"
  }
}